Elizabeth Gordon

Profiling exosomes for the early diagnosis of laryngeal cancer: in their latest work, Marco Bocchetti, Gabriella Misso at University of Campania "Luigi Vanvitelli" and collaborators sought to isolate and characterise exosomes derived from the serum of laryngeal cancer patients using flow cytometry, aiming to identify a specific epitope signature that could be used for early diagnosis https://lnkd.in/gXD2cPvv Their method could enable the development of a cost-effective and minimally invasive liquid biopsy protocol using a simple blood draw, facilitating early diagnosis of lung cancer and improving patient outcomes and quality of life. An article co-authored by Amalia L., Clara Iannarone, Lucia Stefania Pasquale, Michela Falco, Chiara Tammaro, marianna abate, Maria Grazia Ferraro, Raffaele Addeo, Filippo Ricciardiello, Giovanni Motta, Luca De Stefano, Francesco Caraglia, Anna Ceccarelli, Silvia Zappavigna, Marianna Scrima, Alessia Maria Cossu and Michele Caraglia #extracellularvesicles #exosomes #flowcytometry #biomarkers #diagnostic #Vesiculab

34

2 commenti

🔬 A couple of years ago, five patient associations across Europe joined hands with several research groups to develop innovative therapies for #DravetSyndrome. The project SCN1A-UP!, coordinated by Dr Massimo Mantegazza and funded by the EJPRD 2020, aimed to perform pre-clinical studies for developing more effective treatments for Dravet Syndrome with a bottom up approach, targeting SCN1A loss of function. The results of the project will be presented and discussed during a meeting in Rome, on 10 September. For further details, see links in comments ⬇ #DSEF #research #partnership

32

4 commenti

We are happy to present a brand-new DIGI-MEd publication focused on the digitisation process in medicines’ clinical trials from a new European regulations’ perspective.​ ​ IRCCS San Raffaele Hospital's Head of Clinical Research and Development and pharmacologist Professor Carlo Tomino discusses the recent improvements of #EuropeanRegulation on Interventional Drug Clinical Trials (Reg 536/2014) marking a transformative moment for Companies, Healthcare Facilities and Ethics Committees.​ ​ Professor Tomino analyses the European Union's aim to improve the competitiveness of its clinical research processes by aligning them with global regulatory standards and ensuring high level standards of safety and transparency such as the publication of trials' authorizations, progress and outcomes. Moreover, he emphasises the potential of Italy to maintain its leading role in international research endeavours, since Italian researchers and clinical facilities are among the world's best.​ ​ Ultimately, those promising perspectives represent an improved citizens' healthcare for the future, keeping in mind the commitment in using a comprehensible language for them during the care progresses.​ ​ Read the article below to learn more about these important steps towards the digitisation's evolution!​ . ​ #togethermovefirst #digitalmedicine #digitalhealth #clinicaltrials​ ​

13

Interpreting and integrating genomic tests results in clinical cancer care – Overview and practical guidance - raffaella casolino https://lnkd.in/d4n4JWvs Benedikt Westphalen Clare Turnbull Andrew Biankin Philip Beer Nicola Normanno Vivek Subbiah, MD Umberto Malapelle #Cancer #CancerCare #Publication #GenomicTest #CancerResearch #Medicine #Health #Oncology #OncoDaily

23

1 commento